コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 r rhabdomyosarcoma (ARMS), a childhood solid muscle tumor.
2 histiocytosis, and 2 had EBV-positive smooth muscle tumors.
3 osclerosis, asthma, hypertension, and smooth muscle tumors.
4 k-in mice but might be insufficient to cause muscle tumors.
5 EN1-associated esophageal and uterine smooth muscle tumors.
6 bowel disease (IBD), and EBV-related smooth muscle tumors.
7 f NK cells in controlling EBV-related smooth muscle tumors.
8 e currently classified as epithelioid smooth muscle tumors alongside the less predictable, "true" epi
9 cterized by numerous infections, EBV+ smooth muscle tumors, and mucocutaneous inflammation, including
13 s study, we evaluated 43 GISTs and 14 smooth muscle tumors for mutations in the exon 11 of c-kit by a
15 first documented case of EBV-related smooth muscle tumors in the presence of a rare classic NK cell
16 osis (DL), a syndrome of disseminated smooth-muscle tumors involving the esophagus, large airways, an
18 al dominant disorder characterized by smooth-muscle tumors of the skin and uterus and/or renal cancer
19 nd PAX3 chromosomal translocations result in muscle tumors, providing evidence that Pax3 has diverse
22 le in mice gives rise to aggressive skeletal muscle tumors that display the histologic and molecular
23 Uterine leiomyomas are common benign smooth muscle tumors that impose a major burden on women's heal
24 risingly, old mdx mice were prone to develop muscle tumors that resembled the human form of alveolar
25 hepatic EBV-associated posttransplant smooth muscle tumors; therefore, the immunosuppressive treatmen
27 n the tumors and reference tissues, tumor-to-muscle, tumor-to-fat, and tumor-to-urine SI ratios were
30 olved in the pathogenesis of multiple smooth muscle tumors, we examined the 11q13 loss of heterozygos
32 8 malignant and 11 benign GISTs and 7 smooth muscle tumors without mutant bands were cloned and seque
33 ion of TOCSY for the ex vivo study of smooth muscle tumors would potentially serve as a pathologist-i